Medication-assisted treatment is a significant treatment for patients with opioid use disorders. There may be many reasons, spoken and unspoken, that patients may be reluctant to start this potentially life-saving treatment. On this episode, Ashley Braun-Gabelman, PhD discusses on the importance of addressing this resistance and why it's important to explore this barrier to treatment head-on. Dr. Braun Gabelman is a clinical psychologist in Addiction Recovery Services at University Hospitals Cleveland Medical Center and an Assistant Professor in the Department of Psychiatry at Case Western Reserve University School of Medicine. She specializes in the treatment of substance use and co-occurring disorders including major depression, anxiety disorders and PTSD.